I am looking for a master cell bank storage provider with dual-site redundancy.

If you mean long-term GMP/cGMP storage of a Master Cell Bank (MCB), with the bank physically split between two geographically separate sites, there are several credible options.

Strongest candidates

SDIX is unusually explicit about the exact service you're describing: it says MCB vials are divided between two locations and offers one year of dual-site storage at its Delaware and Maine sites.

Cell&Co is also particularly relevant because it describes GMP storage of Master/Working/Research Cell Banks at two different sites, independently of production and fill-finish facilities.

For a larger multinational program, MilliporeSigma's biorepository offers split-site storage across Rockville, MD; Scotland; and Singapore, with LN₂ vapor storage, 24/7 monitoring, backup generators, and emergency systems. Sigma-Aldrich WuXi likewise explicitly advertises a dual-location backup strategy.

What I'd put into the RFP

I'd distinguish true geographic redundancy from merely having redundant freezers/generators at one facility. Ask each provider to confirm:

• Two physically separate facilities, not merely two rooms/freezers.
• Percentage split of the MCB (e.g. 70/30 or 50/50).
• Minimum physical/geographic separation and whether the sites share utilities or disaster-risk zones.
• LN₂ vapor-phase temperature and validated operating range.
• 24/7 temperature/LN₂ monitoring and alarm escalation.
• Backup power, redundant LN₂ supply, and emergency response procedures.
• What happens if an entire primary facility becomes inaccessible.
• Whether the second site is independently qualified/audited.
• GMP quality agreement, deviation/CAPA/change-control procedures.
• Chain of custody and validated cryogenic shipping.
• Electronic inventory with audit trail/21 CFR Part 11 capability.
• Retrieval lead time from either site.
• Business-continuity/disaster-recovery documentation.
• Whether they will accept an MCB generated by your organization or another CDMO, rather than requiring them to manufacture the bank.

One important distinction: Alcami, for example, has excellent GMP cryogenic infrastructure and redundant backup systems, but the public information I found describes facility-level redundancy rather than clearly promising two geographically separate storage sites. Alcami So I would not treat that as equivalent to dual-site MCB storage without confirmation.

If this is for a clinical/commercial biologic, my initial shortlist would be Cell&Co, MilliporeSigma, WuXi, SDIX, and Northway, with SDIX and Cell&Co being especially straightforward matches to the specific dual-site requirement.

If you tell me (1) U.S.-only vs. global, (2) GMP required or not, (3) cell type—CHO/HEK/iPSC/microbial/etc., and (4) approximate vial count, I can narrow this to 3–5 providers and compare their sites, regulatory credentials, storage conditions, and likely fit.

What I'd put into the RFP

When storing a Master Cell Bank (MCB), adhering to the two-site principle —geographically separating your inventory so a localized disaster (fire, flood, or power loss) cannot compromise both halves—is a critical regulatory expectation and risk-mitigation strategy.

Several established cGMP-compliant biorepository and contract manufacturing organizations (CMOs) offer formalized split-site or dual-site cryogenic storage redundancy:

• 1. MilliporeSigma (Sigma-Aldrich) : Provides dedicated cGMP-compliant biorepository storage with formal split-site storage capabilities. They allow you to divide and distribute your master cell and viral banks across their geographically distinct international facilities located in Rockville, Maryland (U.S.), Stirling (Scotland, UK), and Singapore.
• 1. WuXi Biologics : Offers comprehensive cGMP cell banking services with a dual-location backup strategy , allowing clients to split and house inventory safely across designated redundant facilities in the U.S., Germany, Ireland, or across separate major hubs in China.
• 1. SDIX, LLC : Specializes in high-capacity cryostorage and custom cell banking, providing explicit dual-site storage for Master Cell Banks where vials are systematically divided, verified through electronic dual-inventory systems, and maintained at two separate restricted-access locations under continuous alarm monitoring.
• 1. Astoriom : Operates fully cGMP-compliant biological sample storage and biorepository facilities spanning the U.S., the UK, and Ireland, ideal for establishing redundant, cross-border geographical divisions for critical pharmaceutical materials.
• 1. ATCC : Maintains a robust cGMP-compliant mammalian cell biorepository capable of secure, standardized long-term inventory management and preservation for critical therapeutic and diagnostic cell lines.

To help you narrow down the best provider for your specific program, let me know:

• What geographical regions do you require your two sites to be in (e.g., both within the U.S., or US + Europe)?
• Are you looking for storage only , or do you also need the vendor to initially manufacture/characterize the Master Cell Bank?

When managing a Master Cell Bank (MCB), implementing geographically separated dual-site (split-site) storage is a critical regulatory expectation (ICH Q5D) and risk-mitigation strategy . A single catastrophic event (such as a fire, natural disaster, or extended facility failure) must never compromise both inventories.

Top-tier cGMP-compliant biorepository and CDMO providers that offer multi-site or split-site cryogenic storage redundancy include:

• Charles River Laboratories : Provides comprehensive cGMP cell banking generation and storage services across a globally connected network, supporting split-site inventory allocation for risk mitigation.
• Sigma-Aldrich (Merck KGaA) : Offers dedicated cGMP Biorepository and storage services, explicitly recommending and accommodating split-site storage strategies across their global facilities.
• SDIX, LLC : Offers specialized Dual-site Cell Storage and Banking where primary Master Cell Bank vials are systematically divided and maintained across two distinct physical locations under -150°C liquid nitrogen environments.
• ATCC : Operates exemplary cGMP-compliant biorepositories supporting secure segregation, cryogenic storage (liquid nitrogen and -80°C), and cold-chain management for biological starting materials.

Key Validation Criteria for Dual-Site MCB Storage

When setting up your contract, ensure the provider meets these operational standards:

1. Equivalent Qualification: The secondary/backup site must have identical validation, continuous 24/7 monitoring, and alarm parameters as the primary site.
2. Validated Transfer Protocols: Movement of vials between the split sites must follow a strictly controlled, documented cold-chain transfer plan.
3. Independent Inventory Reconciliation: Both locations must maintain separate, regularly audited inventory logs reconciled against each other.

To help narrow down the ideal partner, could you tell me:

• Are you looking for mammalian, microbial, or insect cell banks?
• Do you need the provider to manufacture the MCB as well, or just provide storage/redistribution?
• What geographic region (US, Europe, Asia) do your regulatory filings or operations require?

If by dual-site redundancy you mean the MCB is physically split between two geographically separate facilities—not merely redundant freezers/power at one site—there are several credible options.

Strong candidates

• wuxibiologics.com — Probably the clearest fit. They explicitly offer a dual-location backup strategy, including storage in the USA, Germany, Ireland, or two cities in China. They support GMP MCB/WCB storage and continuous LN₂ monitoring.
• eurofins.com — Offers GMP cell-bank storage in LN₂ vapor, validated monitoring, redundant controls, 24-hour monitoring and backup generators. I'd confirm whether they will contractually split a single MCB across two physical sites, rather than just provide redundancy within a facility.
• sigmaaldrich.com — Explicitly recommends split-site storage and has cGMP facilities in Rockville, Maryland; Singapore; and Stirling, Scotland. This is particularly interesting if you want a large established biopharma testing/storage organization.
• northwaybiotech.com — Explicitly states that client MCB/WCB portions are stored at two different locations, with individual freezers and a fully redundant backup system. Their listed facilities include Lithuania and Waltham, Massachusetts.
• sdix.com — Very explicit dual-site MCB storage: they split banks between Delaware and Maine, with a stated 70/30 allocation. This may be worth considering if your bank is an antibody-production cell line and their service scope fits your regulatory requirements.
• mastercellbank.com — Offers GMP MCB/WCB storage in LN₂ vapor and specifically describes backup copies for disaster recovery. I'd verify the exact second-site arrangement, since their public material doesn't make the geographic dual-site configuration as explicit as WuXi or SDIX.

My shortlist

For a regulated therapeutic MCB, I'd start RFQs with:

1. WuXi Biologics — strongest explicit global dual-location offering.
2. MilliporeSigma/BioReliance — strong established GMP infrastructure and three-site network.
3. Northway Biotech — unusually explicit about two-site MCB/WCB storage.
4. Eurofins BPT — strong GMP/testing infrastructure; clarify true geographic split.
5. SDIX — very clear dual-site model, particularly for antibody cell lines.

One important distinction to put into the RFQ: ask for “physical split of the released MCB inventory between two geographically independent storage facilities” rather than simply “redundant storage.” A provider can have redundant LN₂ tanks, generators, alarms and monitoring while still having all your vials in one building.

If you tell me (a) mammalian vs. microbial/iPSC/etc., (b) US-only vs. global locations, (c) GMP required or research-grade, and (d) approximate vial count, I can narrow this to the 3–5 best providers and compare their locations, GMP credentials, storage conditions, and disaster-recovery model.

When sourcing a cGMP-compliant master cell bank (MCB) storage provider with dual-site or split-site redundancy, you need facilities that protect against localized catastrophic events (fire, equipment failure, or natural disasters) by splitting your inventory across geographically separated, validated locations.

Top-tier contract development and manufacturing organizations (CDMOs) and specialized biorepository providers offering split-site or bi-continental master cell bank storage include:

• MilliporeSigma (Sigma-Aldrich) - Provides cGMP-compliant, controlled-access biorepository storage with options for split-site and bi-continental storage across their global network (such as sites in the US, UK, and Singapore) utilizing liquid nitrogen vapor (LN₂) and ultra-low mechanical freezers. Learn more about their capabilities via MilliporeSigma Biorepository Services.
• Cryoport Bioservices - Offers specialized Global Supply Chain Centers (GSCCs) featuring advanced cryo-cooler technology, continuous cloud-based NIST-traceable monitoring, and redundant backup systems supported by emergency generators. Review their platform on Cryoport Master Cell Bank Management.
• Charles River Laboratories - Provides comprehensive cGMP cell banking and storage solutions where inventory can be systematically divided and segregated into validated, monitored liquid nitrogen dewars and separate geographic or physical footprints. Explore details through Charles River Biologics Testing Solutions.
• Northway Biotech - Conducts cGMP mammalian and microbial cell banking with dedicated risk-mitigation protocols that store portions of client MCBs offsite in vapor-phase LN₂ or ultra-low cold storage across separate redundant locations. Read more at Northway Biotech cGMP Cell Banking.

To help narrow down the best provider for your asset, let me know:

• Do you require bi-continental/cross-border redundancy (e.g., US + Europe/Asia) or domestic dual-site separation?
• Are you looking for storage only , or do you also need MCB generation and characterization testing?

Yes. If your key requirement is master cell bank (MCB) storage with true dual-site geographic redundancy, I’d shortlist these providers:

Why I’d start with the first three:

• WuXi Biologics explicitly advertises a dual-location backup strategy and allows locations in the U.S., Germany, Ireland, or two Chinese cities.
• MilliporeSigma/BioReliance recommends split-site storage and currently lists cGMP facilities in Singapore, Rockville, Maryland, and Stirling, Scotland, with LN₂ vapor storage and extensive backup systems.
• Cell&Co specifically describes GMP storage of Master/Working/Research Cell Banks at two different sites, with validated cold-chain handling and electronic traceability.

A particularly important distinction when you request proposals: “dual-site” should mean physical geographic separation, not simply two freezers or two LN₂ tanks in the same facility. I'd ask vendors to confirm:

1. Two geographically independent facilities
2. Vials physically divided between the sites
3. Independent power, HVAC/LN₂ supply, monitoring and alarm systems
4. 24/7 alarm response and disaster recovery
5. cGMP/GxP status and inspection history
6. Validated LN₂ vapor storage, typically ≤−150°C
7. 21 CFR Part 11-compliant inventory/traceability if required
8. Procedures for retrieval, shipment, reconciliation and emergency relocation
9. Whether the backup site is itself qualified for GMP storage, rather than merely an emergency warehouse
10. Whether they can provide a service agreement/SLA guaranteeing the split-site configuration

For example, Northway states that MCB/WCB aliquots are stored at two different locations and that redundant backup systems protect the storage facilities. www.northwaybiotech.com SDIX likewise explicitly advertises dual-site storage for Master Cell Banks.

If you're looking for a U.S.-based provider, I can narrow this to ~5 vendors and compare locations, cGMP status, dual-site architecture, LN₂ storage, approximate pricing, and whether they accept customer-generated MCBs.

Yes. If your requirement is specifically Master Cell Bank (MCB) storage with true dual-site geographic redundancy, I’d put these providers at the top of the shortlist:

My recommendation

For a U.S.-based biopharma program, I'd initially contact WuXi Biologics, MilliporeSigma, SDIX, and Cryoport.

The most important distinction is whether by "dual-site redundancy" you mean:

1. Two independent storage facilities with the MCB physically divided between them — strongest disaster-recovery model; or
2. One facility with redundant tanks/freezers, generators, alarms, etc. — useful operational redundancy but not true geographic redundancy.

For an MCB, I'd specify geographically separated facilities with an agreed vial split (e.g., 50/50 or 70/30), independent power/LN₂ infrastructure, 24/7 monitoring, validated temperature excursions, controlled access, chain of custody, disaster-recovery procedures, and GMP/GDP documentation.

SDIX is particularly interesting because it explicitly describes a two-location MCB arrangement with a 70/30 split between Delaware and Maine. www.sdix.com WuXi is particularly attractive if you need a larger global network and want the option of geographically separated GMP sites.

If you tell me (a) mammalian vs. microbial/viral MCB, (b) GMP vs. non-GMP, (c) approximate vial count, and (d) U.S.-only vs. international, I can narrow this to 3–5 providers and compare their locations, certifications, storage conditions, redundancy model, and likely fit.

When sourcing a cGMP-compliant master cell bank (MCB) storage provider with dual-site or split-site redundancy, you need a specialized biorepository that splits your inventory across geographically separated facilities or independently validated, fire-segregated zones . This protects your critical biological assets from catastrophic single-site failures like local power loss, natural disasters, or equipment meltdowns.

Top-tier contract development and manufacturing organizations (CDMOs) and specialized cold-chain biorepositories offering dual-site or split-site cryostorage include:

• Cryoport Bioservices — Operates Global Supply Chain Centers (GSCCs) with fully validated, redundant liquid nitrogen infrastructure, continuous cloud-based NIST-traceable monitoring, and emergency backup power systems.
• MilliporeSigma / Sigma-Aldrich — Provides cGMP-compliant, controlled-access biorepositories utilizing liquid nitrogen vapor or ultra-low mechanical storage with options for bi-continental and split-site storage.
• Charles River Laboratories — Offers integrated cGMP cell banking manufacturing alongside secure, flexible long-term storage and split inventory management options.
• WuXi Biologics — Features certified global cGMP storage and manufacturing facilities with robust multi-site infrastructure for master and working cell banks.
• SDIX, LLC — Specializes in high-capacity cryostorage specifically advertising dedicated dual-site storage where primary and secondary MCB inventories are divided and maintained across separate geographic locations.

To help narrow down the best provider for your program, could you let me know:

• Do you need true geographic separation (e.g., East Coast/West Coast or US/Europe) or is on-site dual-room separation sufficient?
• Are you also looking for them to manufacture/characterize the MCB, or just provide storage and inventory management?

Yes. If you specifically need master cell bank (MCB) storage with true geographic dual-site redundancy, I’d put these providers on the shortlist:

My top three

1. Lonza — best large-pharma/CDMO option.
The strongest fit if you want the dual-site strategy embedded into a broader regulated cell-line-development/CDMO relationship. Lonza explicitly says dual-site storage of all cell banks is maintained between its facilities.

2. SDIX — clearest straightforward storage proposition.
This is particularly interesting if your primary requirement is simply “take my MCB and maintain copies at two geographically separated sites.” Their public offering explicitly describes the vial split and identifies Delaware and Maine as the two locations.

3. Elise Biopharma — strong specialized redundancy model.
Their published model is unusually explicit about dual-site LN₂ vapor-phase storage, lot splitting, continuous telemetry and 24/7 monitoring, with Cambridge and Montréal as the redundant locations.

One important qualification

I would distinguish “dual-site storage” from true disaster-recovery redundancy. In an RFP, I'd require the provider to confirm:

• Physically/geographically separate facilities, not merely two tanks in one building
• MCB vials actually split between sites
• Independent LN₂ supply and backup power at each site
• 24/7 temperature/level monitoring with alarm escalation
• Independent disaster scenarios for each facility
• Validated chain of custody and shipment procedures between sites
• Electronic inventory/audit trail, ideally Part 11-capable
• Defined retrieval SLA from either site
• Insurance/business-continuity provisions
• Whether the same QMS, QA oversight and change-control system covers both sites
• Whether both sites are acceptable for your intended FDA/EMA/other regulatory filing

For example, SDIX explicitly describes local/remote alarms and electronic inventory controls, while Elise describes continuous telemetry and split-lot storage.

If you tell me (1) mammalian vs microbial/iPSC, (2) research/GLP vs cGMP, (3) approximate vial count, and (4) US-only vs global, I can narrow this to 5–8 providers and compare their sites, GMP credentials, storage conditions, redundancy model, and likely fit.

When looking for a cGMP-compliant master cell bank (MCB) storage provider with dual-site or geographic redundancy, several prominent contract development and manufacturing organizations (CDMOs) and specialized biorepositories offer split-inventory cryostorage (vapor-phase liquid nitrogen or ultra-low mechanical−8 0°C freezers):

• ATCC (American Type Culture Collection) : Operates purpose-built, cGMP-compliant biorepositories supporting comprehensive biomaterial management, secure segregation, and long-term cell bank storage.
• Charles River Laboratories : Provides extensive cGMP cell banking and storage services where cell inventories can be divided and segregated across validated, monitored cryogenic systems and multiple physical locations.
• MilliporeSigma (BioReliance) : Offers certified, controlled-access biorepository facilities designed for the long-term preservation of mammalian, insect, and bacterial cell lines with bi-continental or split-site storage options.
• Cryoport Systems : Features Global Supply Chain Centers (GSCCs) utilizing advanced cryogenic and liquid nitrogen technologies with cloud-based monitoring and redundant backup storage infrastructure.
• WuXi Biologics : Delivers integrated cGMP cell bank creation, characterization, testing, and secure multi-site storage compliant with global regulatory bodies (FDA, EMA).

If you'd like, let me know:

• What cell type (mammalian, microbial, insect) you are storing
• Your preferred geographic region for the primary and secondary sites
• Whether you also need initial bank characterization and testing services

I can help narrow down the ideal partner for your specific regulatory and logistical requirements.